Screener
CorMedix CRMD Total Revenue
Discontinued — last reported Q1 '26
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue: | ||
| Product sales, net | $121,916 | $39,082 |
| Contract revenue | 5,511 | - |
| Total Revenue | 127,427 | 39,082 |
| Cost of sales (exclusive of amortization of intangibles) | 12,005 | 1,545 |
| Amortization of intangibles | 10,300 | 52 |
| Gross profit | 105,122 | 37,485 |
| Operating Expenses: |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's total revenue?
- CorMedix (CRMD) reported total revenue of $127.43M in Q1 2026.
- How has CorMedix's total revenue changed year-over-year?
- CorMedix's total revenue increased by 226.1% year-over-year, from $39.08M to $127.43M.
- What is the long-term trend for CorMedix's total revenue?
- Over 3 years (2021 to 2025), CorMedix's total revenue has grown at a 1077.5% compound annual growth rate (CAGR), from $190.94K to $311.71M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about CorMedix's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude